Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Riddell

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Treatment and Research|September 26, 2009
Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantationJeffrey Molldrem, Stanley Riddell
Nature|May 26, 2017
Therapeutic T cell engineeringMichel Sadelain, Isabelle Rivière, Stanley Riddell
Haematologica|October 5, 2006
Impact of HLA A2 and cytomegalovirus serostatus on outcomes in patients with leukemia following matched-sibling myeloablative allogeneic hematopoietic cell transplantationVeronique Erard, Katherine A Guthrie, Stanley Riddell, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2011
Analyzing cellular immunity to AAV in a canine model using ELISPOT assayZejing Wang, Rainer Storb, Stephen J Tapscott, et al.
Frontiers in Immunology|January 10, 2018
Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8<sup>+</sup> T-Cell Repertoire in Older PeopleLouise Hosie, Annette Pachnio, Jianmin Zuo, et al.
Human Gene Therapy|December 21, 2007
Induction of transgene-specific cytotoxic T lymphocyte responses after transplantation of gene-modified CD34+ cells despite nonablative immunosuppressive conditioningJulia C Piasecki, Karen Beagles, Brian C Beard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 20, 2004
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytesJinjuan Wang, Oliver W Press, Catherine G Lindgren, et al.
Science Translational Medicine|October 13, 2021
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in miceVandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju, et al.
Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Status of Cytomegalovirus Prevention and Treatment in 2000John A. Zaia, J.G. Patrick Sissons, Stanley Riddell, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Treatment and Research|September 26, 2009
Understanding and enhancing the graft-versus-leukemia effect after hematopoietic stem cell transplantationJeffrey Molldrem, Stanley Riddell
Nature|May 26, 2017
Therapeutic T cell engineeringMichel Sadelain, Isabelle Rivière, Stanley Riddell
Haematologica|October 5, 2006
Impact of HLA A2 and cytomegalovirus serostatus on outcomes in patients with leukemia following matched-sibling myeloablative allogeneic hematopoietic cell transplantationVeronique Erard, Katherine A Guthrie, Stanley Riddell, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2011
Analyzing cellular immunity to AAV in a canine model using ELISPOT assayZejing Wang, Rainer Storb, Stephen J Tapscott, et al.
Frontiers in Immunology|January 10, 2018
Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8<sup>+</sup> T-Cell Repertoire in Older PeopleLouise Hosie, Annette Pachnio, Jianmin Zuo, et al.
Human Gene Therapy|December 21, 2007
Induction of transgene-specific cytotoxic T lymphocyte responses after transplantation of gene-modified CD34+ cells despite nonablative immunosuppressive conditioningJulia C Piasecki, Karen Beagles, Brian C Beard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 20, 2004
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytesJinjuan Wang, Oliver W Press, Catherine G Lindgren, et al.
Science Translational Medicine|October 13, 2021
Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in miceVandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju, et al.
Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.
Hematology. American Society of Hematology. Education Program|November 10, 2001
Status of Cytomegalovirus Prevention and Treatment in 2000John A. Zaia, J.G. Patrick Sissons, Stanley Riddell, et al.
Pageof 2